Military pilots glucose monitors for troops—with strict data safeguards

What it does

This bill directs the Department of Defense to run a five-year pilot program providing continuous glucose monitoring (CGM) devices to active-duty service members who are overweight, obese, prediabetic, or have type 2 diabetes. The goal is to track metabolic health in real time and improve both individual health and military readiness. The bill includes strict data protections: health information cannot be used to discharge or separate members, and private vendors providing the technology cannot retain or reuse the data.

Why we flagged it

The bill is a straightforward pilot program to test continuous glucose monitoring as a preventive health intervention for service members with metabolic risk factors. It is not a procurement mandate, a private-sector subsidy, or a deregulation—it is a time-limited, data-protected health initiative.

What the text implies

• The bill requires participation for members identified as 'Partially Medically Ready' or 'Not Medically Ready,' which may create pressure to participate even though the text does not explicitly mandate it—the word 'require' is ambiguous as to whether refusal is an option.
• The five-year pilot is time-limited, but the Comptroller General's final report (year 5) will recommend whether to extend it; if extended, the program could become permanent without a new legislative vote.
• Data collected under the pilot is restricted to DoD use, but the bill does not address what happens to the data after the five-year period ends—retention, archival, or destruction protocols are not specified.
• The bill targets members in 'Partially Medically Ready' or 'Not Medically Ready' categories, which may disproportionately affect lower-income service members with less access to preventive care before enlistment.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Service members gain access to preventive health technology at no personal cost, with explicit legal protections against punitive use of their health data. The data safeguards—especially the prohibition on using CGM data for medical discharge—protect a vulnerable population (active-duty personnel) from coercive surveillance and career-ending consequences for health conditions.

Who stands to gain

• continuous glucose monitoring device manufacturers
• medical device suppliers to the Department of Defense

Named in the bill

Department of Defense, Secretary of Defense, TRICARE program, Comptroller General of the US, House Committee on Armed Services, Senate Committee on Armed Services, Individual Medical Readiness program, continuous glucose monitoring technology vendors

Where it stands

• Jun 5, 2025 — Introduced · Congress.gov: “Introduced in House”
• Jun 5, 2025 — Referred to House Committee on Armed Services · Congress.gov: “Referred to the House Committee on Armed Services”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.